U.S. Physical Therapy, Inc. (NYSE:USPH) Receives Average Rating of “Buy” from Brokerages

U.S. Physical Therapy, Inc. (NYSE:USPH) has earned a consensus rating of “Buy” from the three brokerages that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $119.50.

A number of brokerages recently commented on USPH. Barrington Research restated an “outperform” rating and set a $122.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, May 9th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. Finally, JPMorgan Chase & Co. boosted their price target on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th.

Insider Activity

In other news, CEO Christopher J. Reading sold 1,100 shares of the company’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $102.13, for a total value of $112,343.00. Following the completion of the sale, the chief executive officer now owns 99,738 shares in the company, valued at $10,186,241.94. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of $105.46, for a total value of $181,813.04. Following the completion of the sale, the chief operating officer now owns 6,970 shares in the company, valued at $735,056.20. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Christopher J. Reading sold 1,100 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $102.13, for a total value of $112,343.00. Following the sale, the chief executive officer now directly owns 99,738 shares of the company’s stock, valued at $10,186,241.94. The disclosure for this sale can be found here. Insiders sold a total of 10,724 shares of company stock worth $1,114,385 over the last 90 days. 1.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Hedge funds have recently modified their holdings of the stock. Northwest Bank & Trust Co purchased a new stake in shares of U.S. Physical Therapy during the fourth quarter valued at $37,000. SRS Capital Advisors Inc. lifted its holdings in shares of U.S. Physical Therapy by 308.0% during the fourth quarter. SRS Capital Advisors Inc. now owns 408 shares of the company’s stock valued at $38,000 after purchasing an additional 308 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of U.S. Physical Therapy by 268.5% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 549 shares of the company’s stock valued at $61,000 after purchasing an additional 400 shares during the last quarter. Advisors Asset Management Inc. lifted its holdings in shares of U.S. Physical Therapy by 78.4% during the first quarter. Advisors Asset Management Inc. now owns 1,056 shares of the company’s stock valued at $119,000 after purchasing an additional 464 shares during the last quarter. Finally, Principal Securities Inc. purchased a new stake in shares of U.S. Physical Therapy during the fourth quarter valued at $100,000.

U.S. Physical Therapy Price Performance

Shares of USPH opened at $92.42 on Friday. The company has a market cap of $1.39 billion, a P/E ratio of 75.14, a PEG ratio of 3.62 and a beta of 1.40. The stock has a fifty day moving average price of $100.29 and a 200 day moving average price of $99.84. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.16 and a quick ratio of 2.16. U.S. Physical Therapy has a 12 month low of $78.08 and a 12 month high of $124.11.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.07). The company had revenue of $155.70 million for the quarter, compared to the consensus estimate of $153.30 million. U.S. Physical Therapy had a return on equity of 8.03% and a net margin of 4.72%. U.S. Physical Therapy’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.59 earnings per share. On average, research analysts forecast that U.S. Physical Therapy will post 2.84 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Thursday, May 23rd were issued a $0.44 dividend. The ex-dividend date of this dividend was Wednesday, May 22nd. This represents a $1.76 annualized dividend and a dividend yield of 1.90%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 143.09%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.